Chandy T, Das G S, Rao G H
Cardiology, University of Minnesota, Minneapolis 55455, USA.
J Microencapsul. 2000 Sep-Oct;17(5):625-38. doi: 10.1080/026520400417676.
The development of injectable microspheres for anticancer drug delivery into the brain is a major challenge. The possibility of entrapping 5-fluorouracil (5-FU) in chitosan coated monodisperse biodegradable microspheres with a mean diameter of 10-25 um was demonstrated. An emulsion of 5-FU (in water) and polylactic acid (PLA) dissolved in acetone-dichloromethane mixture was poured into an aqueous solution of chitosan (or poly-vinyl alcohol) with stirring using a high-speed homogenizer, for the formation of microspheres. 5-FU recovery in microspheres ranged from 44-66% depending on the polymer and emulsification systems used for the preparation. Scanning electron microscopy revealed that the chitosan coated microspheres had less surface micropores compared to PVA based preparations. The drug release behaviour from microspheres suspended in phosphate buffered saline exhibited a biphasic pattern. The amount of drug release was much higher initially (approximately 25%), followed by a constant slow release profile for a 30 days period of study. This chitosan coated PLA/PLGA microsphere formulation may have potential for the targeted delivery of 5-FU to treat cerebral tumours.
开发用于将抗癌药物输送到大脑的可注射微球是一项重大挑战。已证明将5-氟尿嘧啶(5-FU)包裹在平均直径为10-25微米的壳聚糖包被的单分散可生物降解微球中的可能性。将5-FU(溶于水)和溶解在丙酮-二氯甲烷混合物中的聚乳酸(PLA)的乳液倒入壳聚糖(或聚乙烯醇)水溶液中,使用高速均质器搅拌以形成微球。微球中5-FU的回收率在44%-66%之间,具体取决于用于制备的聚合物和乳化体系。扫描电子显微镜显示,与基于聚乙烯醇的制剂相比,壳聚糖包被的微球表面微孔较少。悬浮在磷酸盐缓冲盐水中的微球的药物释放行为呈现双相模式。在为期30天的研究中,最初药物释放量要高得多(约25%),随后是持续的缓慢释放过程。这种壳聚糖包被的PLA/PLGA微球制剂可能具有将5-FU靶向递送至脑肿瘤治疗的潜力。